Full Digital Editions:

Current Issue: Featured Articles

Kasey-Damato-headshot-v2
Life and Career Coaching for NPs and PAs— Negotiating Success for Advanced Practice Practitioners: Strategies for Dealing with a Challenging Boss
by Kasey D’Amato, PA-C, MPAP Ms. D’Amato is President of Certified PA Consulting in Ft. Lauderdale, Florida. J Clin Aesthet Dermatol. 2023;17(1–2 Suppl 1):S42–S43. FUNDING: No funding was provided for...
GDPAAbstracts_Image
Selected Poster Abstracts from 15th Annual Dermatology Pearls Conference
J Clin Aesthet Dermatol. 2024;17(1–2 Suppl 1):S33–S37. Atopic Dermatitis Efficacy and safety of roflumilast cream 0.15% in adults and children aged ≥6 with mild-to-moderate atopic dermatitis in two Phase...
Elevate-DermAbstracts_Image
Selected Poster Abstracts from 4th Annual Elevate-Derm PA & NP Conference
J Clin Aesthet Dermatol. 2024;17(1–2 Suppl 1):S15–S30. Acne Early and sustained reductions in moderate-to-severe acne with fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15%...
Kasey-Damato-headshot-v2
Life and Career Coaching for NPs and PAs— Navigating New Horizons: Exploring the Top 5 Reasons PAs and NPs Pursue Career Changes
J Clin Aesthet Dermatol. 2023;16(12 Suppl 2):S12–S13 by Kasey D’Amato, PA-C, MPAP  Ms. D’Amato is President of Certified PA Consulting in  Ft. Lauderdale, Florida. FUNDING: No funding was provided for...
Sangha
Dermatological Conditions in Skin of Color– Diagnosing and Treating Rosacea in Skin of Color Patients
J Clin Aesthet Dermatol. 2023;16(12 Suppl 2):S14–S15 by Archana M. Sangha, MMS, PA-C  Ms. Sangha is a medical science liaison for Incyte in Wilmington, Delaware. Prior to that, she spent over a decade...
1 2 3 4 5 6 7 8 9 10 11 12 13 14

Trending on JCAD TV

Atopic Dermatitis Advisor Audio Series:

Incorporating Topical and Oral Treatments into Practice

Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alopecia areata. She discusses how utilizing these JAK inhibitors in the treatment of atopic dermatitis has shown to provide a rapid decrease in symptoms, particularly pruritus.